We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

05 Aug 2026 - 07 Aug 2026
18 Aug 2026 - 20 Aug 2026

Alliance to Develop Surgical Ablation System

By HospiMedica staff writers
Posted on 03 Mar 2004
An exclusive multi-year agreement for the development and manufacture of a surgical ablation system to treat cardiac arrhythmias has been announced by Edwards Lifesciences Corp. More...
(Irvine, CA, USA) and PLC Systems, Inc. (Franklin, MA, USA).

Edwards has developed the Optimize surgical ablation system, a cardiac laser designed to treat cardiac arrhythmias. Utilizing a proprietary fiberoptic and diffuser technology, it is designed to create a rise in tissue temperature. Lesions created in this process block the conduction of errant electrical signals in the heart. PLC and Edwards plan to develop the Optimize technology platform as a basis for future, less-invasive products that enable minimally invasive ablation treatment of cardiac arrhythmia.

Under the terms of their agreement, Edwards will transfer to PLC assets and technologies related to its Optimize program. PLC will assume the responsibility of ongoing product development and manufacturing of the Optimize system and disposable components. Edwards will be the exclusive worldwide distributor of these products. PLC and Edwards will jointly own all surgical cardiac ablation intellectual property developed under the agreement.

"By combining the development activities of the Optimize laser and disposable components within a focused organization that specializes in laser technologies, we believe we can further enhance the technology and accelerate the development of less-invasive approaches to this therapy.”




Related Links:
PLC
Edwards

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Resorbable Bovine Collagen Membrane
GenDerm
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image Credit: 123RF

Existing Cardiovascular Risk Calculators Predict Several Common Cancers

Cardiovascular risk calculators are embedded in primary and secondary care to estimate 10‑year risk of heart attack or stroke from factors such as age, body mass index, and smoking. Many of these same... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.